Application 203611
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | TABLET; ORAL | 300MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | TABLET; ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203611-001 | GABAPENTIN | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | |
| A203611-002 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203611-001 | AB2 |
| A203611-002 | AB2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203611-001 | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A203611-002 | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A203611-001 | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A203611-002 | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-001 | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-002 | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203611-001 | AB2 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A203611-002 | AB2 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A203611-001 | AB2 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A203611-002 | AB2 | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-001 | AB2 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-002 | AB2 | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 180b99a5-7d3d-4ee5-a0cc-1ae0ede646ee | 2026-05-04 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 35da078b-0da0-4757-a6c4-a9144c37e8e1 | 2026-05-01 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 38119f2e-33b3-4c3c-99b7-9335d8d280d4 | 2026-05-01 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b8b7e045-a7fe-8539-e053-2a95a90a40f8 | 2026-05-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St Mary's Medical Park Pharmacy | de990f96-96bc-406d-e053-2995a90abebb | 2026-05-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4cb26d6e-7963-4fe5-903e-ab5180545066 | 2026-05-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 100ff86c-56a8-4770-9db3-b9bc6b1bd2f7 | 2026-04-30 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | d22ed424-f365-44ca-8ef9-a08255a90ae8 | 2026-04-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | e3429322-c442-4146-bb68-bcc3a8d01552 | 2026-04-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 2625c0ef-5295-41de-9e81-88001a6cbecc | 2026-04-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 6ecf5114-2ddc-4025-a36d-1884702dc22a | 2026-04-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | f396ec70-826d-45c6-a27c-343c2fac878c | 2026-04-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 41dcc917-68d1-49f0-8223-44c21ca259ef | 2026-04-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Coupler LLC | 5073abda-321f-29d1-e063-6394a90a59ac | 2026-04-27 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | BluePoint Laboratories | 3368bf70-d466-4765-b2b7-7fe967a8c2b7 | 2026-04-24 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 500ee820-0378-6fc9-e063-6394a90a109c | 2026-04-24 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | dd0e12c2-1986-4ca3-a809-d703a7542419 | 2026-04-22 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | PHOENIX RX LLC | 4f95c01f-200e-bfd7-e063-6394a90abc38 | 2026-04-16 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ce0f0d7f-da6d-47da-a4ed-fb8f72902412 | 2026-04-13 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | abb56036-88df-4720-ba78-529971671545 | 2026-04-13 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.